Skip to content

about eci
platform
products
- ophthalmic products
- pipeline
disease states
investors
contact us

Search for:

about eci
platform
products
- ophthalmic products
- pipeline
disease states
investors
contact us

ecitherapeutic

It seems we can’t find what you’re looking for. Perhaps searching can help.

Search for:

ECI researches, develops, and creates breakthrough products – in ophthalmics, wound healing, and burn care – that leverage blood and chitosan to help patients, their family and their community see clearly and lead healthier lives.

ECI Therapeutics products are not FDA approved.

Follow Us

LinkedIn

investor Data Room
(Login Required)

ECI researches, develops, and creates breakthrough products – in ophthalmics, wound healing, and burn care – that leverage blood and chitosan to help patients, their family and their community see clearly and lead healthier lives.

ECI Therapeutics products are not FDA approved.

Investor Data Room
(Login Required)

Content herein may contain certain forward-looking statements relating to Eye Care International, DBA ECI Therapeutics (ECI), that are based on the beliefs of the Company’s management as well as assumptions made by and information currently available to ECI’s management. These forward-looking statements are, by their nature, subject to significant risks and uncertainties. These forward-looking statements include, without limitation, statements relating to the Company’s business prospects, future developments, possible mergers and acquisitions activity, trends and conditions in the industry, its strategies, plans, objectives and goals, its ability to control costs, statements relating to prices, volumes, operations, margins, overall market trends, risk management and exchange rates. As a result of various risks, uncertainties and assumptions, forward-looking events and circumstances discussed herein might not occur in the way ECI expects, or at all. Accordingly, you should not place reliance on any forward-looking information or statements. All forward-looking statements herein are qualified by reference to the cautionary statements set forth in this disclaimer.

Legal Cookie policy Privacy policy

Copyright © 2026 ECI Therapeutics.
ECI Therapeutics is a trademark of Eye Care International (DBA ECI Therapeutics), LLC.

Content herein may contain certain forward-looking statements relating to Eye Care International, DBA ECI Therapeutics (ECI), that are based on the beliefs of the Company’s management as well as assumptions made by and information currently available to ECI’s management. These forward-looking statements are, by their nature, subject to significant risks and uncertainties. These forward-looking statements include, without limitation, statements relating to the Company’s business prospects, future developments, possible mergers and acquisitions activity, trends and conditions in the industry, its strategies, plans, objectives and goals, its ability to control costs, statements relating to prices, volumes, operations, margins, overall market trends, risk management and exchange rates. As a result of various risks, uncertainties and assumptions, forward-looking events and circumstances discussed herein might not occur in the way ECI expects, or at all. Accordingly, you should not place reliance on any forward-looking information or statements. All forward-looking statements herein are qualified by reference to the cautionary statements set forth in this disclaimer.

legal
cookie policy
privacy policy

Copyright © 2026 ECI Therapeutics.
ECI Therapeutics is a trademark of Eye Care International (DBA ECI Therapeutics), LLC.